Merck anti covid pill: ‘leaflet’, how it works and when it should be taken

Merck’s anti covid pill will need to be taken 2 times a day for 5 days to cure the disease. Therapy should begin within 5 days of the first symptoms. The indications of the European drug agency Ema on the antiviral pill molnupiravir for the treatment of Covid-19, developed by Merck Sharp & Dohme (Merck in the USA and Canada) in collaboration with Ridgeback Biotherapeutics, arrive. Read also The therapy, according to the advice issued by the Committee for Medicinal Products for Human Use CHMP of the EU regulatory body, must begin “as soon as possible” after diagnosis, and “within 5 days of the onset of symptoms”. The drug, which is available in capsules, will need to be taken “2 times a day for 5 days”. Its use “is not recommended in pregnancy”. And breastfeeding “must be discontinued during treatment and for 4 days after treatment.” These are some of the main contents of the ‘Advice’ released by the panel of experts on the use of Lagevrio * (also known as MK 4482). The opinion, reads an Ema note, was issued to support the national authorities of the various Member States who could decide on a possible early use of the medicine before the European marketing authorization, for example in emergency contexts. in light of rising rates of infection and deaths from Covid across the EU. (continues)